Trial Profile
Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs Tick-borne encephalitis vaccine (Primary)
- Indications Encephalitis
- Focus Pharmacodynamics
- 28 Jan 2022 Primary endpoint (log titre of TBE virus-specific neutralizing antibodies on day 400) has been met according to the results published in the Vaccine
- 28 Jan 2022 Results published in the Vaccine
- 17 Nov 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.